NEW YORK (Reuters Health) - Two studies released Tuesday report the identification of several genetic mutations that influence the risk of developing the bone-thinning disease osteoporosis and ...

The Food and Drug Administration on Tuesday approved an osteoporosis drug that represents the first new treatment approach in nearly two decades — a strategy based on a rare gene mutation in people ...

A genetic analysis suggests that a rare form of osteoporosis may be partly caused by disruptions to the hormone melatonin. When you purchase through links on our site, we may earn an affiliate ...

Are you due for a bone density test? The U.S. Preventive Services Task Force announced updated osteoporosis screening guidelines on January 14, 2025. Women 65 years or older, or postmenopausal women ...

As we age, the health of our bones becomes increasingly important. Osteoporosis, a condition characterized by weakened bones, affects millions, leading to fractures and reduced quality of life. Among ...